Autoimmunity and inflammation are independent of class II transactivator type PIV-dependent class II major histocompatibility complex expression in peripheral tissues during collagen-induced arthritis

Arthritis and Rheumatism

Volumn 63, Issue 11, 2011, Pages 3354-3363

  Waldburger, Jean Marc ^a   Palmer, Gaby ^a   Seemayer, Christian ^b,f   Lamacchia, Celine ^a   Finckh, Axel ^c   Christofilopoulos, Panayiotis ^c   Baeten, Dominique ^d   Reith, Walter ^a   Gabay, Cem ^e  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^f NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAJOR HISTOCOMPATIBILITY COMPLEX TRANSACTIVATOR PI; MAJOR HISTOCOMPATIBILITY COMPLEX TRANSACTIVATOR PIII; MAJOR HISTOCOMPATIBILITY COMPLEX TRANSACTIVATOR PIV; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MOUSE; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; TRANSGENIC MOUSE;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOIMMUNITY; CARTILAGE, ARTICULAR; HIP JOINT; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INFLAMMATION; KNEE JOINT; MICE; MICE, KNOCKOUT; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; SYNOVIAL MEMBRANE; T-LYMPHOCYTES; TRANS-ACTIVATORS;

EID: 80155204630     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30522     Document Type: Article

References (38)

1. Burmester GR, Jahn B, Rohwer P, Zacher J, Winchester RJ, Kalden JR,. Differential expression of Ia antigens by rheumatoid synovial lining cells. J Clin Invest 1987; 80: 595-604. (Pubitemid 18003927)
2. Zimmermann T, Kunisch E, Pfeiffer R, Hirth A, Stahl HD, Sack U, et al. Isolation and characterization of rheumatoid arthritis synovial fibroblasts from primary culture: primary culture cells markedly differ from fourth-passage cells. Arthritis Res 2001; 3: 72-6. (Pubitemid 32223808)
3. Kubota H, Okada K, Sato K, Sageshima M,. HLA-DR expression of synovium and correlation with clinical features of patients with rheumatoid arthritis. Tohoku J Exp Med 2000; 190: 177-84.
4. Tran CN, Davis MJ, Tesmer LA, Endres JL, Motyl CD, Smuda C, et al. Presentation of arthritogenic peptide to antigen-specific T cells by fibroblast-like synoviocytes. Arthritis Rheum 2007; 56: 1497-506. (Pubitemid 46764078)
5. Kraft M, Filsinger S, Kramer KL, Kabelitz D, Hansch GM, Schoels M,. Synovial fibroblasts as accessory cells for staphylococcal enterotoxin-mediated T-cell activation. Immunology 1995; 85: 461-6.
6. Boots AM, Wimmers-Bertens AJ, Rijnders AW,. Antigen-presenting capacity of rheumatoid synovial fibroblasts. Immunology 1994; 82: 268-74. (Pubitemid 24241743)
7. Corrigall VM, Solau-Gervais E, Panayi GS,. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes. Arthritis Rheum 2000; 43: 1606-15. (Pubitemid 30452482)
8. Tran CN, Thacker SG, Louie DM, Oliver J, White PT, Endres JL, et al. Interactions of T cells with fibroblast-like synoviocytes: role of the B7 family costimulatory ligand B7-H3. J Immunol 2008; 180: 2989-98.
9. Reith W, LeibundGut-Landmann S, Waldburger JM,. Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 2005; 5: 793-806. (Pubitemid 41400853)
10. Otten LA, Steimle V, Bontron S, Mach B,. Quantitative control of MHC class II expression by the transactivator CIITA. Eur J Immunol 1998; 28: 473-8. (Pubitemid 28101722)
11. Van der Stoep N, Quinten E, Alblas G, Plancke A, van Eggermond MC, Holling TM, et al. Constitutive and IFNγ-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region. Mol Immunol 2007; 44: 2036-46.
12. LeibundGut-Landmann S, Waldburger JM, Reis e Sousa C, Acha-Orbea H, Reith W,. MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells. Nat Immunol 2004; 5: 899-908. (Pubitemid 39276234)
13. Waldburger JM, Suter T, Fontana A, Acha-Orbea H, Reith W,. Selective abrogation of major histocompatibility complex class II expression on extrahematopoietic cells in mice lacking promoter IV of the class II transactivator gene. J Exp Med 2001; 194: 393-406. (Pubitemid 32835036)
14. + T cells. Blood 2003; 101: 3550-9. (Pubitemid 36857941)
15. + thymocytes control mature medullary thymic epithelial cell cellularity. Immunity 2008; 29: 451-63.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24. (Pubitemid 18091653)
17. Baeten D, Van den Bosch F, Elewaut D, Stuer A, Veys EM, De Keyser F,. Needle arthroscopy of the knee with synovial biopsy sampling: technical experience in 150 patients. Clin Rheumatol 1999; 18: 434-41. (Pubitemid 30014161)
18. Landmann S, Muhlethaler-Mottet A, Bernasconi L, Suter T, Waldburger JM, Masternak K, et al. Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression. J Exp Med 2001; 194: 379-91. (Pubitemid 32835035)
19. Magne D, Palmer G, Barton JL, Mezin F, Talabot-Ayer D, Bas S, et al. The new IL-1 family member IL-1F8 stimulates production of inflammatory mediators by synovial fibroblasts and articular chondrocytes. Arthritis Res Ther 2006; 8: R80.
20. Marinova-Mutafchieva L, Williams RO, Funa K, Maini RN, Zvaifler NJ,. Inflammation is preceded by tumor necrosis factor- dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 2002; 46: 507-13. (Pubitemid 34136589)
21. Palmer G, Talabot-Ayer D, Lamacchia C, Toy D, Seemayer CA, Viatte S, et al. Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 2009; 60: 738-49.
22. Palmer G, Chobaz V, Talabot-Ayer D, Taylor S, So A, Gabay C, et al. Assessment of the efficacy of different statins in murine collagen-induced arthritis. Arthritis Rheum 2004; 50: 4051-9. (Pubitemid 39643955)
23. Bartok B, Firestein GS,. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev 2010; 233: 233-55.
24. Chang SK, Gu Z, Brenner MB,. Fibroblast-like synoviocytes in inflammatory arthritis pathology: the emerging role of cadherin-11. Immunol Rev 2010; 233: 256-66.
25. Ospelt C, Gay S,. The role of resident synovial cells in destructive arthritis. Best Pract Res Clin Rheumatol 2008; 22: 239-52. (Pubitemid 351606943)
26. Saijo S, Asano M, Horai R, Yamamoto H, Iwakura Y,. Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells. Arthritis Rheum 2002; 46: 533-44. (Pubitemid 34136592)
27. Lamacchia C, Palmer G, Seemayer CA, Talabot-Ayer D, Gabay C,. Enhanced Th1 and Th17 responses and arthritis severity in mice with a deficiency of myeloid cell-specific interleukin-1 receptor antagonist. Arthritis Rheum 2010; 62: 452-62.
28. Johnson WJ, Kelley A, Connor JR, Dalton BJ, Meunier PC,. Inhibition of IFN-γ-induced Ia antigen expression on synovial fibroblasts by IL-1. J Immunol 1989; 143: 1614-8. (Pubitemid 19217427)
29. Neumann E, Lefevre S, Zimmermann B, Gay S, Muller-Ladner U,. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010; 16: 458-68.
30. Zrioual S, Ecochard R, Tournadre A, Lenief V, Cazalis MA, Miossec P,. Genome-wide comparison between IL-17A- and IL-17F-induced effects in human rheumatoid arthritis synoviocytes. J Immunol 2009; 182: 3112-20.
31. Muhlethaler-Mottet A, Otten LA, Steimle V, Mach B,. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA. EMBO J 1997; 16: 2851-60. (Pubitemid 27226221)
32. Romieu-Mourez R, Francois M, Boivin MN, Stagg J, Galipeau J,. Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-γ, TGF-β, and cell density. J Immunol 2007; 179: 1549-58.
33. Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP,. Identification of distinct regions of 5â flanking DNA that mediate constitutive, IFN-γ, STAT1, and TGF-β-regulated expression of the class II transactivator gene. J Immunol 1998; 160: 233-40. (Pubitemid 28116734)
34. + T cell responses develop independent of thymic epithelial MHC. Proc Natl Acad Sci U S A 2006; 103: 14435-40. (Pubitemid 44484768)
35. Luross JA, Williams NA,. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 2001; 103: 407-16. (Pubitemid 32744386)
36. Alvaro-Gracia JM, Zvaifler NJ, Firestein GS,. Cytokines in chronic inflammatory arthritis. V. Mutual antagonism between interferon-γ and tumor necrosis factor-α on HLA-DR expression, proliferation, collagenase production, and granulocyte macrophage colony-stimulating factor production by rheumatoid arthritis synoviocytes. J Clin Invest 1990; 86: 1790-8.
37. Kanazawa S, Ota S, Sekine C, Tada T, Otsuka T, Okamoto T, et al. Aberrant MHC class II expression in mouse joints leads to arthritis with extraarticular manifestations similar to rheumatoid arthritis. Proc Natl Acad Sci U S A 2006; 103: 14465-70. (Pubitemid 44484773)
38. Schooten E, Klous P, van den Elsen PJ, Holling TM,. Lack of MHC-II expression in activated mouse T cells correlates with DNA methylation at the CIITA-PIII region. Immunogenetics 2005; 57: 795-9. (Pubitemid 41598626)